Journal of Clinical Epidemiology
Volume 55, Issue 4 , Pages 358-363 , April 2002

Incidence of chronic atrial fibrillation in general practice and its treatment pattern

  • Ana Ruigómez

      Affiliations

    • Centro Español de Investigación Farmacoepidemiológica (CEIFE), c/Almirante 28, 2°, 28004 Madrid, Spain
  • ,
  • Saga Johansson

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • Section of Preventive Cardiology, Göteborg University, Göteborg, Sweden
  • ,
  • Mari-Ann Wallander

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • Department of Public Health and Caring Science, Uppsala University, Uppsala, Sweden
  • ,
  • Luis Alberto Garcı́a Rodrı́guez

      Affiliations

    • Centro Español de Investigación Farmacoepidemiológica (CEIFE), c/Almirante 28, 2°, 28004 Madrid, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34-97-531-34-04; fax: +34-97-531-28-71. E-mail address:(L.A. Garcia Rodriguez)

Received 21 March 2001 ,Revised 19 September 2001 ,Accepted 21 September 2001.

References 

  1. Domanski MJ. The epidemiology of atrial fibrillation. Coronary Artery Dis. 1995;6:95–100
  2. Kannel WB, Wolf PA. Epidemiology of atrial fibrillation. In:  Falk RH,  Podrid PJ editor. Atrial fibrillation (mechanisms and management). New York: Raven Press Ltd; 1992;
  3. Cuddy TE, Connolly SJ. Atrial fibrillation and atrial flutter. Can J Cardiol. 1996;12(SupplA):9–11
  4. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455–2461
  5. Kalman JM, Tonkin AM. Atrial fibrillation (epidemiology and the risk and prevention of stroke). PACE. 1992;15:1332–1346
  6. The Atrial Fibrillation Investigators . Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449–1457
  7. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ. 1997;314:1529–1530
  8. Albers GW, Yim JM, Belew KM, Bittar N, Hattmer CR, et al.  Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med. 1996;156(20):2311–2316
  9. Adhiyaman V, Kamalakannan D, Oke A, Shah IU, White AD. Underutilization of antihrombotic therapy in atrial fibrillation. J R Soc Med. 2000;93(3):138–140
  10. Garcı́a Rodrı́guez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998;45:419–426
  11. Lévy S, Breithardt G, Campbell RWF, Camm AJ, Daubert J-C, et al.  Atrial fibrillation (current knowledge and recommendations for management). Eur Heart J. 1998;19:1294–1320
  12. Perez I, Melbourn A, Kalra L. Use of antithrombotic measures for stroke prevention in atrial fibrillation. Heart. 1999;82:570–574
  13. Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Prospective cohort study to determine if trial efficacy of antiacoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ. 2000;320:1236–1239
  14. Walker AM. Case-control studies (sampling the source population). In:  Walker AM editors. Observation and inference (an introduction to the methods of epidemiology). Chestnut Hill,MA: Epidemiology Resources Inc; 1991;p. 75–80
  15. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840–844
  16. Asher CR, Miller DP, Grimm RA, Cosgrove DM, Chung MK. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol. 1998;82(7):892–895
  17. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation (population-based estimates). Am J Cardiol. 1998;82(8A):2–9
  18. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation (incidence, risk factors, and prognosis in the Manitoba Follow-Up Study). Am J Med. 1995;98(5):476–484
  19. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI. A survey of atrial fibrillation in general practice (the West Birmingham Atrial Fibrillation Project). Br J Gen Pract. 1997;47(418):285–289
  20. The Atrial Fibrillation Investigators . The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators. Arch Intern Med. 1997;157(11):1237–1240
  21. Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol. 1999;84(9A):131–138
  22. Langenberg M, Hellemons BSP, vanRee JW, Vermeer F, Lodder J, Schouten HJA, et al. Atrial fibrillation in the elderly patients (prevalence and comorbidity in general practice). BMJ. 1996;313:1534
  23. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation.Analysis and implications. Arch Intern Med. 1995;155:469–473
  24. Morley J, Marinchak R, Rials SJ, Kowey P. Atrial fibrillation, anticoagulation, and stroke. Am J Cardiol. 1996;77(3):38A–44A
  25. Brass LB, Krumholz HM, Scinto JD, Deepak M, Radford M. Warfarin use following ischemic stroke among medicare patients with atrial fibrillation. Arch Internal Med. 1998;158:2093–2100
  26. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selvy JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation (the anticoagulation and risk factors in atrial fibrillation (ATRIA) study). Ann Intern Med. 1999;131:927–934
  27. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin?. Arch Intern Med. 2000;160(1):41–46
  28. Reardon M, Camm AJ. Atrial fibrillation in the elderly. Clin Cardiol. 1996;19(10):765–775

PII: S0895-4356(01)00478-4

Journal of Clinical Epidemiology
Volume 55, Issue 4 , Pages 358-363 , April 2002